Home > News > Nanogen Issued Patents
May 24th, 2005
Nanogen Issued Patents
Abstract:
Nanogen, Inc., developer of advanced diagnostic products, announced today it was issued two
patents from the U.S. Patent and Trademark Office, including U.S. Patent No. 6,891,154, "Amino Acid Sequence Pattern Matching" and No. 6,893,822, "Enzymatic modification of a nucleic acid-synthetic binding unit conjugate." Nanogen's growing portfolio of 128 U.S. patents now includes intellectual
property related to novel biomarker discovery technology and methods of isolating nucleic acids on a microarray.
Source:
prnewswire
Related News Press |
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||